Dabigatran is an oral direct thrombin inhibitor. Dabigatran was found to be noninferior to Warfarin in prevention of ischemic stroke, as well as intracranial hemorrhage risk and overall mortality for non-valvular atrial fibrillation according to the RE-LY trial. Monitoring No influence of obesity on...